v3.25.1
Equity and Non-Controlling Interests (Details Narrative) - USD ($)
 3 Months Ended
Sep. 20, 2023
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2024
Class of Stock [Line Items]        
Preferred stock, shares authorized   10,000,000 10,000,000  
Preferred stock, shares issued   0 0  
Preferred stock, shares outstanding   0 0  
Capital infusions   $ 55,896    
Exozyme Technologies Inc [Member]        
Class of Stock [Line Items]        
Equity interest rate       60.94%
Minimum [Member] | Minnesota One [Member]        
Class of Stock [Line Items]        
Equity interest rate   67.52%    
Maximum [Member] | Minnesota One [Member]        
Class of Stock [Line Items]        
Equity interest rate   67.87%    
Minnesota One [Member] | Weighted Average [Member]        
Class of Stock [Line Items]        
Subsidiary, Ownership Percentage, Parent   67.78%   60.94%
Subsidiary, Ownership Percentage, Noncontrolling Owner   32.22%   39.06%
Common Class A [Member]        
Class of Stock [Line Items]        
Common stock, shares authorized   95,000,000 95,000,000  
Common stock, shares, issued   4,950,632 4,950,632  
Common stock, shares, outstanding   4,950,632 4,950,632  
Voting rights   one vote per share    
Common Class A [Member] | Private Placement [Member]        
Class of Stock [Line Items]        
Placement agent and selling agent warrants   43,420    
Common Class A [Member] | IPO [Member]        
Class of Stock [Line Items]        
Placement agent and selling agent warrants 1,666,666 43,420    
Common Class B [Member]        
Class of Stock [Line Items]        
Common stock, shares authorized   5,000,000 5,000,000  
Common stock, shares, issued   5,000,000 5,000,000  
Common stock, shares, outstanding   5,000,000 5,000,000  
Voting rights   five votes per share